ORGANON & CO (OGN:NYSE)
$13.53 -0.01 (-0.0739%)
Analysed ORGANON & CO (OGN:NYSE) News Sources
Can Organon & Co. (OGN)’s MIUDELLA Launch Become a Major Driver in Women’s Health Markets?
30-06-2026
yahoo.com
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know
03-07-2026
yahoo.com
Organon to Present New Analysis on VTAMA® (tapinarof) cream, 1%, at the 2026 Society for Pediatric Dermatology Annual Meeting
07-07-2026
yahoo.com
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It
15-07-2026
yahoo.com
Organon to Report Second Quarter 2026 Results in Its Regularly Scheduled Form 10-Q Filing
16-07-2026
yahoo.com
ORGANON CANADA ANNOUNCES THE APPOINTMENT OF DOMINIC BÉGIN AS PRESIDENT AND MANAGING DIRECTOR
22-07-2026
yahoo.com
Organon (OGN) Names A Canada Chief, Is The Stock Cheap?
23-07-2026
yahoo.com
Organon & Co. Shareholders Clear Sun Pharma Merger Deal
23-07-2026
marketbeat.com
New Analysis of Phase 3 Pooled Data for Organon’s VTAMA® (tapinarof) cream, 1%, Demonstrates Early, Consistent Improvements in Atopic Dermatitis Patients Across Pediatric Age Groups and in Adults1
24-07-2026
yahoo.com
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
28-07-2026
yahoo.com
What is the current price of ORGANON & CO (OGN:NYSE)?
The current price of ORGANON & CO (OGN:NYSE) is $13.53.
ORGANON & CO (OGN:NYSE) absolute price change since previous trading day?
The absolute price change of ORGANON & CO (OGN:NYSE) since the previous trading day is $-0.01.
ORGANON & CO (OGN:NYSE) percentage price change since previous trading day?
The percentage price change of ORGANON & CO (OGN:NYSE) since the previous trading day is -0.0739%.
What is the most recent average sentiment score for ORGANON & CO (OGN:NYSE)?
The most recent average sentiment score for ORGANON & CO (OGN:NYSE) is 65 out of 100.
What is the most recent average sentiment for ORGANON & CO (OGN:NYSE)?
The most recent sentiment for ORGANON & CO (OGN:NYSE) is .
SEC-8K** Filing Available For ORGANON & CO (OGN:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.